Clinical Trial Update: Evaluation of Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial compares Loteprednol Etabonate with vehicle for treating inflammation and pain after cataract surgery, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Inflammation
• Postoperative Pain

Drugs mentioned

• LOTEPREDNOL ETABONATE (Loteprednol etabonate)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Inflammation, Pain | Phase 3 | Status: COMPLETED | Results posted: 2012-01-13